Last month, Dr Peter French took to the stage to represent BCAL Dx at the final global round of the 1776 Challenge Cup. This follows BCAL Dx’s successful regional round in Singapore earlier this year.
BCAL Dx was one of 60 finalists in the global round and one of only five companies to progress through to the global round from the Asia-Pacific regional finals.
The Challenge has taken place over the last six months, in 45 cities around the world. Judges had to select from over 1000 startups to progress through to the regional finals, culminating in the global finals with only a handful organisations – of which BCAL Dx was one.
The Challenge was an effective networking opportunity for BCAL Dx, with the opportunity to meet a number of connectors and potential investment partners with a specific interest in medical biotechnology. BCAL Dx was also hosted by the staff of the Australian Embassy, where we discussed the expanding biotech market and how to leverage Australia-US relations in this space.
1776 is a global incubator and seed fund helping startups transform industries that impact millions of lives every day—education, energy & sustainability, health, transportation and cities.